Results 181 to 190 of about 16,063 (220)
Some of the next articles are maybe not open access.

SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10.

Cell, 2010
A hallmark of Alzheimer's disease (AD) is the accumulation of plaques of Abeta 1-40 and 1-42 peptides, which result from the sequential cleavage of APP by the beta and gamma-secretases. The production of Abeta peptides is avoided by alternate cleavage of APP by the alpha and gamma-secretases.
Gizem, Donmez   +3 more
openaire   +1 more source

Regulation of alpha-secretase ADAM10 expression and activity

Experimental Brain Research, 2011
The amyloid precursor protein (APP) has a pivotal role in pathogenesis of Alzheimer's disease (AD) via its beta- and gamma-secretase-derived cleavage products--the A-beta peptides. An alternative processing pathway provided by the alpha-secretase prevents formation of those toxic peptides and gives rise to the neurotrophic and neuroprotective cleavage ...
Kristina, Endres, Falk, Fahrenholz
openaire   +2 more sources

Protein kinase C epsilon suppresses Abeta production and promotes activation of alpha-secretase.

Biochemical and biophysical research communications, 2001
Deposition of plaques containing Abeta is considered important in the pathogenesis of Alzheimer's disease. Phorbol esters that activate protein kinase C (PKC) promote alpha-secretase-mediated processing of the beta amyloid precursor protein (APP), which generally reduces formation of Abeta.
G, Zhu   +5 more
openaire   +1 more source

Alpha-Secretase Cleavage of the Amyloid Precursor Protein: Proteolysis Regulated by Signaling Pathways and Protein Trafficking

Current Alzheimer Research, 2012
α-secretase is the name for a metalloprotease activity, which is assumed to play a key role in the prevention of the molecular mechanisms underlying Alzheimer's disease (AD). Proteases similar to α-secretase are essential for a wide range of biological processes, such as cell adhesion and embryonic development.
openaire   +3 more sources

Acitretin, an Enhancer of Alpha-Secretase Expression, Crosses the Blood-Brain Barrier and Is Not Eliminated by P-Glycoprotein

Neurodegenerative Diseases, 2012
<i>Background:</i> ADAM10 (a disintegrin and metalloproteinase 10) has been demonstrated to act as the main physiological α-secretase. Enzymatic activity of the α-secretase on the one hand prevents the formation of toxic Aβ peptides and on the other hand promotes the secretion of a neurotrophic and neuroprotective amyloid precursor protein ...
David, Holthoewer   +5 more
openaire   +2 more sources

Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus.

Neuroreport, 2002
The amyloid cascade hypothesis suggests that amyloid precursor protein (APP) proteolytic processing is a key event in the pathogenesis of Alzheimer's disease (AD). The enzymes beta-site APP cleaving enzyme (BACE) and A disintegrin and metalloproteinase 10 (ADAM10) play an important role in APP proteolysis.
GATTA LB   +3 more
openaire   +2 more sources

Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17.

Current Alzheimer research, 2008
Disintegrin metalloproteases of the ADAM family form a large (at present > 40 members in mammals) family of multidomain membrane proteins that in their ectodomain combine a cystein-rich, disintegrin and a zinc metalloprotease domain. Via their metalloprotease domain, ADAMs are often implicated in ectodomain shedding, either to release e.g.
Miriam, Deuss   +2 more
openaire   +1 more source

[Effect of an inhibitor of alpha-secretase metabolizing amyloid precursor protein on memory in rats].

Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova, 2006
Intracortical administration of 10(-4) M batimastat, a specific inhibitor of one of metalloproteinases metabolizing amyloid precursor protein, namely alpha-secretase, to adult rats resulted in a decrease in the number of correct runs in a one-level 8-arm maze down to 92.78 +/- 1.03% of the control values (p < 0.01) already 60 min after an injection ...
N M, Dubrovskaia   +3 more
openaire   +1 more source

The neuropeptide PACAP promotes the alpha-secretase pathway for processing the Alzheimer amyloid precursor protein.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006
The neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) has neurotrophic as well as anti-apoptotic properties and is involved in learning and memory processes. Its specific G protein-coupled receptor PAC1 is expressed in several central nervous system (CNS) regions, including the hippocampal formation. Here we examined the effect of
Elzbieta, Kojro   +5 more
openaire   +1 more source

[S2‐01‐01]: Alpha‐secretase as a therapeutic target

Alzheimer's & Dementia, 2005
Falk Fahrenholz   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy